Welcome to our dedicated page for Align Technology news (Ticker: ALGN), a resource for investors and traders seeking the latest updates and insights on Align Technology stock.
Align Technology, Inc. (NASDAQ: ALGN) is a global medical device company best known for the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software. The ALGN news feed on Stock Titan aggregates company announcements, clinical product updates, financial disclosures, and professional education highlights directly relevant to investors and dental professionals.
Recent news shows Align focusing on digital orthodontics and restorative dentistry, with updates on innovations such as ClinCheck® Live Plan for automated Invisalign treatment planning, new features for iTero Digital Solutions, and expanded availability of Invisalign System options like mandibular advancement with occlusal blocks for Class II correction in growing patients. News items also cover Align’s participation in major dental congresses, including the Greater New York Dental Meeting, where the company showcases its Align™ Digital Platform and related tools.
Investors following ALGN news will see regular earnings announcements and outlook updates, including quarterly revenue, clear aligner volumes, imaging systems and CAD/CAM services performance, and commentary on geographic trends. SEC-related press releases, such as those tied to Form 8-K filings on financial results or leadership changes, also appear in the news flow.
Align’s communications further highlight research, education, and community programs, including its Annual Research Award Program for university-based dental research and partnerships with organizations like the Canadian Foundation for the Advancement of Orthodontics through Smiles4Canada. For users tracking ALGN, this news page offers a centralized view of product launches, clinical innovations, financial milestones, and corporate initiatives that shape the company’s role in digital dentistry.
Align Technology (Nasdaq: ALGN) announces significant innovations in its Invisalign system aimed at enhancing digital orthodontics. Key features include ClinCheck Live Update for real-time treatment plan modifications, the Invisalign Practice App for mobile management, and the Invisalign Personalized Plan (IPP) for streamlined treatment preferences. These enhancements are designed to improve efficiency, patient outcomes, and overall practice productivity. Align's commitment to continuous innovation is underscored by leveraging data from over 12 million cases, enhancing both the doctor and patient experience.
Align Technology (Nasdaq: ALGN) will report its fourth quarter and full year 2021 financial results on February 2, 2022, after market close. The results will be available on the company's Investor Relations website at 4:00 p.m. ET. Following this, a conference call will take place at 4:30 p.m. ET to discuss the results, accessible via an audio webcast. Tentative earnings release dates for fiscal 2022 are also announced, with the first quarter on April 27, 2022.
Align Technology has announced a significant $1 million donation to the American Association of Orthodontists Foundation (AAOF), aimed at enhancing orthodontic education and research. This donation, to be distributed over five years, reflects Align's commitment to advancing the science of orthodontics. The AAOF, since its inception, has awarded $14.6 million for educational and research initiatives, benefiting orthodontic professionals and their patients. Align has been a corporate partner with the AAOF since 2017, demonstrating ongoing support for the orthodontic community.
Align Technology (Nasdaq: ALGN) announces its participation in upcoming financial conferences, with presentations available for streaming on their Investor Relations website. The company will be featured at the Jefferies London Healthcare Conference on November 18, 2021, and the Piper Sandler 33rd Annual Virtual Healthcare Conference on November 30, 2021, where key executives will present insights. Align Technology specializes in innovative solutions for orthodontics and restorative dentistry, including the Invisalign system and iTero scanners.
Align Technology has opened its 2022 Research Award Program, offering up to $375,000 in funding to support dental research at universities globally. This initiative aims to enhance clinical and scientific research in orthodontics and dentistry. Since the program's launch in 2010, Align has allocated approximately $2.4 million in research funding. The awards, available across the Americas, EMEA, and APAC, will fund five one-year projects of up to $25,000 each. Applications are due by March 4, 2022.
Align Technology, Inc. (ALGN) has announced a new accelerated stock repurchase (ASR) agreement with Citibank to repurchase $100 million of its common stock. This repurchase is part of Align's $1 billion stock repurchase program initiated on May 13, 2021. Under this agreement, Align will initially receive approximately 128,100 shares, with the final share count based on the stock's average price during the ASR term. The transaction, set to complete in about three months, will be funded using Align's cash reserves, which totaled $1.2 billion as of September 30, 2021.
Align Technology announced the results of a clinical study published in the Journal of Dentistry, demonstrating that the iTero Element 5D imaging system with NIRI technology outperforms traditional bitewing radiography in detecting early enamel lesions by 66%. The study indicated a detection accuracy of 88.6% for early enamel lesions and 96.9% for carious lesions. Conducted across five dental clinics in Germany and Canada, the iTero system offers a radiation-free option for caries detection, enhancing dental assessments and treatment options for patients.
Align Technology reported Q3'21 revenues of $1.016 billion, a 38.4% increase year-over-year and a 0.5% sequential rise. Clear Aligner revenues stood at $837.6 million, up 34.9% year-over-year but down 0.4% sequentially. The company achieved an operating margin of 25.7%, a slight decrease from the previous quarter. Notably, the total volume of Clear Aligners for teens rose 26.6% year-over-year. Align’s cash and equivalents reached $1.2 billion as of Sept 30, 2021. Outlook for FY 2021 anticipates revenues between $3.90 billion and $3.95 billion, indicating growth of 58% to 60% compared to 2020.
Align Technology (Nasdaq: ALGN) announced a hybrid Investor Day on October 29, 2021, from 4:00 p.m. to 8:30 p.m. Eastern Time. The event aims to provide insights on the company's advancements in digital orthodontics and restorative dentistry, leveraging the Invisalign system and iTero scanners.
Virtual participants must register in advance via the provided link. The meeting will be broadcast live, and a replay will be available on Align's website for three months post-event. For inquiries, contact Courtney Clemons at 408-591-0379.
Align Technology (Nasdaq: ALGN) announced it will release its third quarter 2021 financial results on October 27, 2021, after market close. Results will be accessible on the company’s Investor Relations website at 4:00 p.m. ET. A conference call will follow at 4:30 p.m. ET to discuss the results, available via audio webcast. Archived webcasts will be accessible for one month post-call. Align specializes in the Invisalign system, iTero scanners, and exocad software, serving over 200,000 doctors and having treated approximately 10.9 million patients globally.